MAPK11 - N-terminal region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-MAPK11 - N-terminal region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMAPK11 - N-terminal region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciescow, human, mouse, rat, zebrafish
Isotypen/a
Formataffinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against MK11. It was validated on Western BlotTarget Description: This gene encodes a member of a family of protein kinases that are involved in the integration of biochemical signals for a wide variety of cellular processes, including cell proliferation, differentiation, transcriptional regulation, and development. The encoded protein can be activated by proinflammatory cytokines and environmental stresses through phosphorylation by mitogen activated protein kinase kinases (MKKs). Alternative splicing results in multiple transcript variants.
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the N-terminal region of Human MK11
Other Names[mitogen-activated protein kinase 11; Mitogen-activated protein kinase 11; mitogen-activated protein kinase 11; mitogen-activated protein kinase 11; Mitogen-activated protein kinase p38 beta; MAP kinase p38 beta; p38b; Stress-activated protein kinase 2b; SAPK2b; p38-2]
Gene, Accession #[MAPK11], Gene ID: 5600, NCBI: NP_002742, UniProt: Q15759
Catalog #MBS3212771
Price$335
Order / More InfoMAPK11 - N-terminal region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.